134 related articles for article (PubMed ID: 30153702)
1. Molecular pathogenesis of renal cell carcinoma: Impact of the anti-tumor miR-29 family on gene regulation.
Yamada Y; Sugawara S; Arai T; Kojima S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
Int J Urol; 2018 Nov; 25(11):953-965. PubMed ID: 30153702
[TBL] [Abstract][Full Text] [Related]
2. Impact of novel oncogenic pathways regulated by antitumor miR-451a in renal cell carcinoma.
Yamada Y; Arai T; Sugawara S; Okato A; Kato M; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2018 Apr; 109(4):1239-1253. PubMed ID: 29417701
[TBL] [Abstract][Full Text] [Related]
3. Regulation of LOXL2 and SERPINH1 by antitumor microRNA-29a in lung cancer with idiopathic pulmonary fibrosis.
Kamikawaji K; Seki N; Watanabe M; Mataki H; Kumamoto T; Takagi K; Mizuno K; Inoue H
J Hum Genet; 2016 Dec; 61(12):985-993. PubMed ID: 27488440
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-218 inhibits cell migration and invasion in renal cell carcinoma through targeting caveolin-2 involved in focal adhesion pathway.
Yamasaki T; Seki N; Yoshino H; Itesako T; Hidaka H; Yamada Y; Tatarano S; Yonezawa T; Kinoshita T; Nakagawa M; Enokida H
J Urol; 2013 Sep; 190(3):1059-68. PubMed ID: 23454155
[TBL] [Abstract][Full Text] [Related]
5. Expression and functional role of miR-29b in renal cell carcinoma.
Xu Y; Zhu J; Lei Z; Wan L; Zhu X; Ye F; Tong Y
Int J Clin Exp Pathol; 2015; 8(11):14161-70. PubMed ID: 26823729
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.
Yamamoto N; Kinoshita T; Nohata N; Yoshino H; Itesako T; Fujimura L; Mitsuhashi A; Usui H; Enokida H; Nakagawa M; Shozu M; Seki N
Int J Oncol; 2013 Dec; 43(6):1855-63. PubMed ID: 24141696
[TBL] [Abstract][Full Text] [Related]
7. Regulation of antitumor miR-144-5p targets oncogenes: Direct regulation of syndecan-3 and its clinical significance.
Yamada Y; Arai T; Kojima S; Sugawara S; Kato M; Okato A; Yamazaki K; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2018 Sep; 109(9):2919-2936. PubMed ID: 29968393
[TBL] [Abstract][Full Text] [Related]
8. miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.
Khella HW; Bakhet M; Allo G; Jewett MA; Girgis AH; Latif A; Girgis H; Von Both I; Bjarnason GA; Yousef GM
Carcinogenesis; 2013 Oct; 34(10):2231-9. PubMed ID: 23715501
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-200b is downregulated and suppresses metastasis by targeting LAMA4 in renal cell carcinoma.
Li Y; Guan B; Liu J; Zhang Z; He S; Zhan Y; Su B; Han H; Zhang X; Wang B; Li X; Zhou L; Zhao W
EBioMedicine; 2019 Jun; 44():439-451. PubMed ID: 31130475
[TBL] [Abstract][Full Text] [Related]
10. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
Xu M; Gu M; Zhang K; Zhou J; Wang Z; Da J
Diagn Pathol; 2015 Apr; 10():24. PubMed ID: 25890121
[TBL] [Abstract][Full Text] [Related]
11. Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma.
Yamada Y; Hidaka H; Seki N; Yoshino H; Yamasaki T; Itesako T; Nakagawa M; Enokida H
Cancer Sci; 2013 Mar; 104(3):304-12. PubMed ID: 23176581
[TBL] [Abstract][Full Text] [Related]
12. Regulation of spindle and kinetochore-associated protein 1 by antitumor miR-10a-5p in renal cell carcinoma.
Arai T; Okato A; Kojima S; Idichi T; Koshizuka K; Kurozumi A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
Cancer Sci; 2017 Oct; 108(10):2088-2101. PubMed ID: 28746769
[TBL] [Abstract][Full Text] [Related]
13. miR-1293 Suppresses Tumor Malignancy by Targeting Hydrocyanic Oxidase 2: Therapeutic Potential of a miR-1293/Hydrocyanic Oxidase 2 Axis in Renal Cell Carcinoma.
Liu XL; Pan WG; Li KL; Mao YJ; Liu SD; Zhang RM
Cancer Biother Radiopharm; 2020 Jun; 35(5):377-386. PubMed ID: 31971830
[TBL] [Abstract][Full Text] [Related]
14. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma.
Lin C; Li Z; Chen P; Quan J; Pan X; Zhao L; Zhou L; Lai Y; He T; Xu W; Xu J; Guan X; Li H; Yang S; Hu Y; Lai Y
Life Sci; 2018 Sep; 209():481-489. PubMed ID: 30138594
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
Nofech-Mozes R; Khella HW; Scorilas A; Youssef L; Krylov SN; Lianidou E; Sidiropoulos KG; Gabril M; Evans A; Yousef GM
Cancer Med; 2016 Apr; 5(4):656-64. PubMed ID: 26860079
[TBL] [Abstract][Full Text] [Related]
16. Regulation of aberrantly expressed SERPINH1 by antitumor miR-148a-5p inhibits cancer cell aggressiveness in gastric cancer.
Kawagoe K; Wada M; Idichi T; Okada R; Yamada Y; Moriya S; Okubo K; Matsushita D; Arigami T; Kurahara H; Maemura K; Natsugoe S; Seki N
J Hum Genet; 2020 Aug; 65(8):647-656. PubMed ID: 32235846
[TBL] [Abstract][Full Text] [Related]
17. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
[TBL] [Abstract][Full Text] [Related]
18. Dual Strands of Pre-miR-149 Inhibit Cancer Cell Migration and Invasion through Targeting FOXM1 in Renal Cell Carcinoma.
Okato A; Arai T; Yamada Y; Sugawara S; Koshizuka K; Fujimura L; Kurozumi A; Kato M; Kojima S; Naya Y; Ichikawa T; Seki N
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28902136
[TBL] [Abstract][Full Text] [Related]
19. microRNA-200c modulates the epithelial-to-mesenchymal transition in human renal cell carcinoma metastasis.
Wang X; Chen X; Wang R; Xiao P; Xu Z; Chen L; Hang W; Ruan A; Yang H; Zhang X
Oncol Rep; 2013 Aug; 30(2):643-50. PubMed ID: 23754305
[TBL] [Abstract][Full Text] [Related]
20. Tumour-suppressive microRNA-29s directly regulate LOXL2 expression and inhibit cancer cell migration and invasion in renal cell carcinoma.
Nishikawa R; Chiyomaru T; Enokida H; Inoguchi S; Ishihara T; Matsushita R; Goto Y; Fukumoto I; Nakagawa M; Seki N
FEBS Lett; 2015 Jul; 589(16):2136-45. PubMed ID: 26096783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
